v3.25.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Assets [Abstract]    
Cash and cash equivalents $ 387,520 $ 377,099
Cash collateral posted to counterparties 318,317 244,440
Mortgage-backed securities (including pledged of $9,066,756 and $6,893,629, respectively), at fair value 10,510,006 7,512,087
Due from counterparties 12,349 10,445
Derivative assets 31,816 133
Accrued interest receivable 43,309 32,841
Other assets 7,948 7,534
Total assets 11,311,265 8,184,579
Liabilities:    
Repurchase agreements 8,600,143 6,563,120
Due to counterparties 976,506 341,924
Derivative liabilities 31 22,814
Cash collateral posted by counterparties 29,323 0
Accrued interest payable 60,855 44,672
Accrued dividends payable 26,125 16,501
Other liabilities 8,289 10,612
 Total liabilities 9,701,272 6,999,643
Preferred Stock, Liquidation Preference, Value 111,500 111,500
Stockholders' Equity Attributable to Parent [Abstract]    
Preferred stock, par value $0.01 per share; 50,000,000 shares authorized; 4,460,000 and 4,460,000 shares issued and outstanding, respectively ($111,500 and $111,500 aggregate liquidation preference, respectively) 107,843 107,843
Common stock, par value $0.01 per share, 360,000,000 shares authorized; 125,358,375 and 84,491,800 shares issued and outstanding, respectively 1,253 845
Additional paid-in capital 2,268,143 1,742,471
Accumulated other comprehensive loss (149,035) (172,489)
Accumulated deficit (618,211) (493,734)
 Total shareholders’ equity 1,609,993 1,184,936
Total liabilities and shareholders’ equity $ 11,311,265 $ 8,184,579

Source

10-Q PDF XBRL Zip